PMID: 3110248Jul 1, 1987

A comparison of the effects of sodium cromoglycate and beclomethasone dipropionate on pulmonary function and bronchial hyperreactivity in subjects with asthma

The Journal of Allergy and Clinical Immunology
U G SvendsenB Weeke


After a run-in period of 2 weeks, receiving a regimen of inhaled beta 2-agonists and/or theophyllines, 38 atopic patients with asthma with perennial symptoms were randomly allocated to receive an 8-week treatment of additional inhalation treatment with either sodium cromoglycate (SCG), 2 mg four times daily, and placebo beclomethasone dipropionate (BDP), or BDP, 200 micrograms twice daily, and placebo SCG. After crossover, each group received the opposite treatment for the final 8 weeks. FEV1, FVC, and provocation concentration of histamine causing a 20% fall in FEV1 (PC20) were determined monthly and peak expiratory flow (PEF) daily throughout the study. A significant increase in FEV1, FVC, and PEF (p less than 0.01) was observed after BDP treatment was started, and likewise, in the second period, an increase in both FEV1 and PEF (p less than 0.05) was observed. The total effect on logarithm-natural (Ln) (PC20), i.e., the mean effects of the two periods, was also significant (p less than 0.01). SCG, however, was most effective when it was used as the first drug, indicated by a significant increase in FVC in the first period (p less than 0.05). Neither in the first nor in the second period did SCG treatment influence the Ln (PC...Continue Reading


May 1, 1989·Respiratory Medicine·P König
Nov 30, 1989·The New England Journal of Medicine·P J Barnes
Jan 10, 1993·The New England Journal of Medicine·E R McFadden, I A Gilbert
Jan 1, 1994·Mediators of Inflammation·E A Valletta, A L Boner
Mar 20, 2001·Pharmacotherapy·K V Blake
Oct 23, 2001·Respiratory Research·Y R Vasquez, D Spina
Mar 22, 1997·Lancet·P M O'Byrne
Nov 1, 1991·The Journal of Allergy and Clinical Immunology·G G ShapiroC W Bierman
Feb 13, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T Haahtela
Jul 1, 1996·Pediatric Pulmonology·F M de BenedictisH Levison
May 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H MagnussenD Nowak
Jan 1, 1995·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M B Emanuel, P H Howarth
May 1, 1992·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J K SontP J Sterk
Jan 1, 1991·Allergy·L HaugaardP A Ostergaard
Sep 20, 1997·The Annals of Pharmacotherapy·L Hendeles, P L Marshik
Apr 21, 2006·The Cochrane Database of Systematic Reviews·J P GuevaraJ Zorc

Related Concepts

Lobar Bronchus Structure

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.


This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.